It Seems Biodelivery Sciences International Inc (NASDAQ:BDSI) Will Go Down. Just Reported More Shorted Shares

BioDelivery Sciences International, Inc. (NASDAQ:BDSI) Logo

Investors sentiment increased to 1.04 in 2018 Q2. Its up 0.27, from 0.77 in 2018Q1. It is positive, as 8 investors sold BioDelivery Sciences International, Inc. shares while 15 reduced holdings. 12 funds opened positions while 12 raised stakes. 24.84 million shares or 9.49% more from 22.69 million shares in 2018Q1 were reported.
Manufacturers Life Ins Co The accumulated 2,697 shares. Deutsche Bank Ag owns 6,351 shares. California Pub Employees Retirement Sys holds 259,400 shares. 29,940 were reported by Goldman Sachs Grp Inc Inc. Grp Inc One Trading L P holds 0% in BioDelivery Sciences International, Inc. (NASDAQ:BDSI) or 8,430 shares. Us Natl Bank De, a Minnesota-based fund reported 200 shares. Morgan Stanley stated it has 122,383 shares or 0% of all its holdings. Ghost Tree Capital Limited Liability Corp holds 1.41 million shares. The Kentucky-based Alphamark Advisors Ltd Liability Corp has invested 0% in BioDelivery Sciences International, Inc. (NASDAQ:BDSI). Next Group owns 0.07% invested in BioDelivery Sciences International, Inc. (NASDAQ:BDSI) for 62,850 shares. Millennium Management Limited Liability Company invested in 149,471 shares or 0% of the stock. Moreover, Weiss Asset Management Limited Partnership has 0% invested in BioDelivery Sciences International, Inc. (NASDAQ:BDSI). Vanguard Gru Inc stated it has 2.37M shares. Armistice Ltd Liability Co holds 0.02% or 120,889 shares in its portfolio. Ameriprise holds 1.11M shares.

Since August 17, 2018, it had 0 insider purchases, and 4 selling transactions for $503,324 activity.

The stock of Biodelivery Sciences International Inc (NASDAQ:BDSI) registered an increase of 2.42% in short interest. BDSI’s total short interest was 2.64M shares in December as published by FINRA. Its up 2.42% from 2.57M shares, reported previously. With 419,400 shares average volume, it will take short sellers 6 days to cover their BDSI’s short positions. The short interest to Biodelivery Sciences International Inc’s float is 6.42%.

The stock increased 3.43% or $0.13 during the last trading session, reaching $3.92. About 201,421 shares traded. BioDelivery Sciences International, Inc. (NASDAQ:BDSI) has declined 3.33% since December 6, 2017 and is downtrending. It has underperformed by 18.95% the S&P500.

BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products principally in the areas of pain management and addiction. The company has market cap of $277.11 million. The firm provides its products based on its patented BioErodible MucoAdhesive drug delivery technology, which consists of a small, erodible polymer film for application to the buccal mucosa. It currently has negative earnings. It offers ONSOLIS, a fentanyl buccal soluble film to treat breakthrough pain in opioid patients with cancer; BUNAVAIL, a buprenorphine and naloxone buccal film for the treatment of opioid dependence; and BELBUCA, a buprenorphine buccal film for the treatment of chronic pain.

More notable recent BioDelivery Sciences International, Inc. (NASDAQ:BDSI) news were published by: which released: “BioDelivery Sciences Announces BELBUCA® Patent Litigation Settlement Agreement with Teva – GlobeNewswire” on February 06, 2018, also with their article: “Drug/Biotech Stock Q2 Earnings on Aug 9: PRGO, BDSI & More – Nasdaq” published on August 08, 2018, published: “BioDelivery Sciences to Present at the 2018 Janney Montgomery Scott Healthcare Conference – GlobeNewswire” on September 10, 2018. More interesting news about BioDelivery Sciences International, Inc. (NASDAQ:BDSI) were released by: and their article: “Raleigh pharma ushers in new CEO from Allergan – Triangle Business Journal” published on May 08, 2018 as well as‘s news article titled: “The Daily Biotech Pulse: SITC Presentations Pick Up Pace, Sandoz’ Voluntary Recall – Benzinga” with publication date: November 09, 2018.

BioDelivery Sciences International, Inc. (NASDAQ:BDSI) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.